Mind Medicine (MindMed) Inc (MNMD)

[DarthYoda]

Companion bills filed by Sen. Bill Cassidy (R-LA) and Rep. Morgan Griffith (R-VA) largely reflect a plan that was recently released by the White House’s Office of National Drug Control Policy (ONDCP), with the backing of the Drug Enforcement Administration (DEA).

Titled the Halt All Lethal Trafficking of (HALT) Fentanyl Act, the main intent of the identical companion measures is to curb trafficking of the powerful opioid. While reform advocates have expressed concern about provisions that would permanently place fentanyl analogues in the strictest federal drug category, the legislation also contains provisions to streamline the research process for all Schedule I drugs under the Controlled Substances Act. That strict category currently includes cannabis as well as psychedelics like LSD, mescaline and MDMA.

H.R.6184 - HALT Fentanyl Act
https://www.congress.gov/bill/117th-congress/house-bill/6184/cosponsors

S.3336 - HALT Fentanyl Act
https://www.congress.gov/bill/117th-congress/senate-bill/3336

https://www.whitehouse.gov/ondcp/briefing-room/2021/09/02/biden-harris-administration-provides-recommendations-to-congress-on-reducing-illicit-fentanyl-related-substances/

https://www.marijuanamoment.net/gop-lawmakers-file-bills-to-streamline-research-into-marijuana-psychedelics-and-other-schedule-i-drugs/